Literature DB >> 19480222

To adhere or not to adhere--patients selectively decide.

Alec B Platt1, Samuel T Kuna.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19480222      PMCID： PMC2675890          DOI： 10.1093/sleep/32.5.583

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  15 in total

1.  Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

Authors:  Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

2.  Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome.

Authors:  Liam S Doherty; John L Kiely; Valerie Swan; Walter T McNicholas
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

3.  Night-to-night variability in CPAP use over the first three months of treatment.

Authors:  T E Weaver; N B Kribbs; A I Pack; L R Kline; D K Chugh; G Maislin; P L Smith; A R Schwartz; N M Schubert; K A Gillen; D F Dinges
Journal:  Sleep       Date:  1997-04       Impact factor: 5.849

4.  Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

Authors:  Bradi B Granger; Karl Swedberg; Inger Ekman; Christopher B Granger; Bertil Olofsson; John J V McMurray; Salim Yusuf; Eric L Michelson; Marc A Pfeffer
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

5.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure.

Authors:  Francisco Campos-Rodriguez; Nicolas Peña-Griñan; Nuria Reyes-Nuñez; Ines De la Cruz-Moron; Jose Perez-Ronchel; Francisco De la Vega-Gallardo; Ana Fernandez-Palacin
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

8.  Treatment adherence and risk of death after a myocardial infarction.

Authors:  R I Horwitz; C M Viscoli; L Berkman; R M Donaldson; S M Horwitz; C J Murray; D F Ransohoff; J Sindelar
Journal:  Lancet       Date:  1990-09-01       Impact factor: 79.321

9.  Neighborhood of residence is associated with daily adherence to CPAP therapy.

Authors:  Alec B Platt; Samuel H Field; David A Asch; Zhen Chen; Nirav P Patel; Rajesh Gupta; Dominic F Roche; Indira Gurubhagavatula; Jason D Christie; Samuel T Kuna
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

10.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Authors: 
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245
View more
  2 in total

1.  Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect.

Authors:  Alec B Platt; Samuel T Kuna; Samuel H Field; Zhen Chen; Rajesh Gupta; Dominic F Roche; Jason D Christie; David A Asch
Journal:  Chest       Date:  2009-10-09       Impact factor: 9.410

2.  Predictors of continuous positive airway pressure adherence.

Authors:  Peter G Catcheside
Journal:  F1000 Med Rep       Date:  2010-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.